Paul M. Tyler

Improving the quantification of Brownian motion

Ashley R. Carter, J. G. Trapani, Marco A. Catipovic, 2013 .

Targeting Cytokine Therapy to the Pancreatic Tumor Microenvironment Using PD-L1–Specific VHHs

Lestat R. Ali, H. Ploegh, U. V. von Andrian, 2018, Cancer Immunology Research.

Monoclonal Invariant NKT (iNKT) Cell Mice Reveal a Role for Both Tissue of Origin and the TCR in Development of iNKT Functional Subsets

H. Ploegh, P. Brennan, S. Dougan, 2017, The Journal of Immunology.

Subsets the TCR in Development of iNKT Functional Reveal a Role for Both Tissue of Origin and Monoclonal Invariant NKT ( iNKT ) Cell Mice

H. Ploegh, P. Brennan, S. Dougan, 2017 .

Human PI3Kγ deficiency and its microbiota-dependent mouse model reveal immunodeficiency and tissue immunopathology

J. McElwee, S. Pittaluga, Y. Zhang, 2019, Nature Communications.

Clinical Dosing Regimen of Selinexor Maintains Normal Immune Homeostasis and T-cell Effector Function in Mice: Implications for Combination with Immunotherapy

B. Klebanov, S. Dougan, Y. Landesman, 2016, Molecular Cancer Therapeutics.

Altered Binding of Tumor Antigenic Peptides to MHC Class I Affects CD8+ T Cell–Effector Responses

Lestat R. Ali, M. Birnbaum, S. Dougan, 2018, Cancer Immunology Research.

Human autoinflammatory disease reveals ELF4 as a transcriptional regulator of inflammation

A. Griffiths, N. Warner, W. Ji, 2021, Nature Immunology.